The global market for Overexpression Stable Cell Lines Service was valued at US$ 219 million in the year 2024 and is projected to reach a revised size of US$ 318 million by 2031, growing at a CAGR of 5.4% during the forecast period.
Overexpression Stable Cell Line Service is a specialized biotechnology service aimed at constructing a population of transgenic cells capable of expressing a target gene or protein at a consistently high level over an extended period of time. The process typically involves introducing the target gene into a host cell (e.g. mammalian, bacterial or insect cells) using a viral vector or plasmid, followed by screening and cloning to isolate cells that stably integrate the transgene into their genome. The resulting stable cell lines are genetically engineered to maintain stable gene expression without significant loss of function over multiple passages, which is critical for research (e.g., studying protein function, drug screening) and bioproduction (e.g., production of recombinant proteins, antibodies). By ensuring reliable and sustained overexpression, these services enable scientists to overcome the limitations of transient transfection methods and provide a stable platform for downstream applications requiring sustained protein production or long-term cellular modeling.
North American market for Overexpression Stable Cell Lines Service is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Overexpression Stable Cell Lines Service is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Overexpression Stable Cell Lines Service in Biomedical Research is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Overexpression Stable Cell Lines Service include VectorBuilder, System Biosciences, CROBiosystems, Sino Biological, Cyagen, Ubigene, GenScript, AcceGen, Creative Biogene, OriGene, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Overexpression Stable Cell Lines Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Overexpression Stable Cell Lines Service.
The Overexpression Stable Cell Lines Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Overexpression Stable Cell Lines Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Overexpression Stable Cell Lines Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
VectorBuilder
System Biosciences
CROBiosystems
Sino Biological
Cyagen
Ubigene
GenScript
AcceGen
Creative Biogene
OriGene
Vitro Biotech
Cusabio
EDITGENE
System Biosciences, LLC
Acres Biosciences
Alstembio
Creative Bioarray
Segment by Type
Single-cell Clone Deliverables
Cell Pool Clone Deliverables
Segment by Application
Biomedical Research
Drug Discovery and Development
Basic Cell Biology and Biotechnology
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Overexpression Stable Cell Lines Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Overexpression Stable Cell Lines Service Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Single-cell Clone Deliverables
1.2.3 Cell Pool Clone Deliverables
1.3 Market by Application
1.3.1 Global Overexpression Stable Cell Lines Service Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Biomedical Research
1.3.3 Drug Discovery and Development
1.3.4 Basic Cell Biology and Biotechnology
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Overexpression Stable Cell Lines Service Market Perspective (2020-2031)
2.2 Global Overexpression Stable Cell Lines Service Growth Trends by Region
2.2.1 Global Overexpression Stable Cell Lines Service Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Overexpression Stable Cell Lines Service Historic Market Size by Region (2020-2025)
2.2.3 Overexpression Stable Cell Lines Service Forecasted Market Size by Region (2026-2031)
2.3 Overexpression Stable Cell Lines Service Market Dynamics
2.3.1 Overexpression Stable Cell Lines Service Industry Trends
2.3.2 Overexpression Stable Cell Lines Service Market Drivers
2.3.3 Overexpression Stable Cell Lines Service Market Challenges
2.3.4 Overexpression Stable Cell Lines Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Overexpression Stable Cell Lines Service Players by Revenue
3.1.1 Global Top Overexpression Stable Cell Lines Service Players by Revenue (2020-2025)
3.1.2 Global Overexpression Stable Cell Lines Service Revenue Market Share by Players (2020-2025)
3.2 Global Top Overexpression Stable Cell Lines Service Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Overexpression Stable Cell Lines Service Revenue
3.4 Global Overexpression Stable Cell Lines Service Market Concentration Ratio
3.4.1 Global Overexpression Stable Cell Lines Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Overexpression Stable Cell Lines Service Revenue in 2024
3.5 Global Key Players of Overexpression Stable Cell Lines Service Head office and Area Served
3.6 Global Key Players of Overexpression Stable Cell Lines Service, Product and Application
3.7 Global Key Players of Overexpression Stable Cell Lines Service, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Overexpression Stable Cell Lines Service Breakdown Data by Type
4.1 Global Overexpression Stable Cell Lines Service Historic Market Size by Type (2020-2025)
4.2 Global Overexpression Stable Cell Lines Service Forecasted Market Size by Type (2026-2031)
5 Overexpression Stable Cell Lines Service Breakdown Data by Application
5.1 Global Overexpression Stable Cell Lines Service Historic Market Size by Application (2020-2025)
5.2 Global Overexpression Stable Cell Lines Service Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Overexpression Stable Cell Lines Service Market Size (2020-2031)
6.2 North America Overexpression Stable Cell Lines Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Overexpression Stable Cell Lines Service Market Size by Country (2020-2025)
6.4 North America Overexpression Stable Cell Lines Service Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Overexpression Stable Cell Lines Service Market Size (2020-2031)
7.2 Europe Overexpression Stable Cell Lines Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Overexpression Stable Cell Lines Service Market Size by Country (2020-2025)
7.4 Europe Overexpression Stable Cell Lines Service Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Overexpression Stable Cell Lines Service Market Size (2020-2031)
8.2 Asia-Pacific Overexpression Stable Cell Lines Service Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Overexpression Stable Cell Lines Service Market Size by Region (2020-2025)
8.4 Asia-Pacific Overexpression Stable Cell Lines Service Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Overexpression Stable Cell Lines Service Market Size (2020-2031)
9.2 Latin America Overexpression Stable Cell Lines Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Overexpression Stable Cell Lines Service Market Size by Country (2020-2025)
9.4 Latin America Overexpression Stable Cell Lines Service Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Overexpression Stable Cell Lines Service Market Size (2020-2031)
10.2 Middle East & Africa Overexpression Stable Cell Lines Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Overexpression Stable Cell Lines Service Market Size by Country (2020-2025)
10.4 Middle East & Africa Overexpression Stable Cell Lines Service Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 VectorBuilder
11.1.1 VectorBuilder Company Details
11.1.2 VectorBuilder Business Overview
11.1.3 VectorBuilder Overexpression Stable Cell Lines Service Introduction
11.1.4 VectorBuilder Revenue in Overexpression Stable Cell Lines Service Business (2020-2025)
11.1.5 VectorBuilder Recent Development
11.2 System Biosciences
11.2.1 System Biosciences Company Details
11.2.2 System Biosciences Business Overview
11.2.3 System Biosciences Overexpression Stable Cell Lines Service Introduction
11.2.4 System Biosciences Revenue in Overexpression Stable Cell Lines Service Business (2020-2025)
11.2.5 System Biosciences Recent Development
11.3 CROBiosystems
11.3.1 CROBiosystems Company Details
11.3.2 CROBiosystems Business Overview
11.3.3 CROBiosystems Overexpression Stable Cell Lines Service Introduction
11.3.4 CROBiosystems Revenue in Overexpression Stable Cell Lines Service Business (2020-2025)
11.3.5 CROBiosystems Recent Development
11.4 Sino Biological
11.4.1 Sino Biological Company Details
11.4.2 Sino Biological Business Overview
11.4.3 Sino Biological Overexpression Stable Cell Lines Service Introduction
11.4.4 Sino Biological Revenue in Overexpression Stable Cell Lines Service Business (2020-2025)
11.4.5 Sino Biological Recent Development
11.5 Cyagen
11.5.1 Cyagen Company Details
11.5.2 Cyagen Business Overview
11.5.3 Cyagen Overexpression Stable Cell Lines Service Introduction
11.5.4 Cyagen Revenue in Overexpression Stable Cell Lines Service Business (2020-2025)
11.5.5 Cyagen Recent Development
11.6 Ubigene
11.6.1 Ubigene Company Details
11.6.2 Ubigene Business Overview
11.6.3 Ubigene Overexpression Stable Cell Lines Service Introduction
11.6.4 Ubigene Revenue in Overexpression Stable Cell Lines Service Business (2020-2025)
11.6.5 Ubigene Recent Development
11.7 GenScript
11.7.1 GenScript Company Details
11.7.2 GenScript Business Overview
11.7.3 GenScript Overexpression Stable Cell Lines Service Introduction
11.7.4 GenScript Revenue in Overexpression Stable Cell Lines Service Business (2020-2025)
11.7.5 GenScript Recent Development
11.8 AcceGen
11.8.1 AcceGen Company Details
11.8.2 AcceGen Business Overview
11.8.3 AcceGen Overexpression Stable Cell Lines Service Introduction
11.8.4 AcceGen Revenue in Overexpression Stable Cell Lines Service Business (2020-2025)
11.8.5 AcceGen Recent Development
11.9 Creative Biogene
11.9.1 Creative Biogene Company Details
11.9.2 Creative Biogene Business Overview
11.9.3 Creative Biogene Overexpression Stable Cell Lines Service Introduction
11.9.4 Creative Biogene Revenue in Overexpression Stable Cell Lines Service Business (2020-2025)
11.9.5 Creative Biogene Recent Development
11.10 OriGene
11.10.1 OriGene Company Details
11.10.2 OriGene Business Overview
11.10.3 OriGene Overexpression Stable Cell Lines Service Introduction
11.10.4 OriGene Revenue in Overexpression Stable Cell Lines Service Business (2020-2025)
11.10.5 OriGene Recent Development
11.11 Vitro Biotech
11.11.1 Vitro Biotech Company Details
11.11.2 Vitro Biotech Business Overview
11.11.3 Vitro Biotech Overexpression Stable Cell Lines Service Introduction
11.11.4 Vitro Biotech Revenue in Overexpression Stable Cell Lines Service Business (2020-2025)
11.11.5 Vitro Biotech Recent Development
11.12 Cusabio
11.12.1 Cusabio Company Details
11.12.2 Cusabio Business Overview
11.12.3 Cusabio Overexpression Stable Cell Lines Service Introduction
11.12.4 Cusabio Revenue in Overexpression Stable Cell Lines Service Business (2020-2025)
11.12.5 Cusabio Recent Development
11.13 EDITGENE
11.13.1 EDITGENE Company Details
11.13.2 EDITGENE Business Overview
11.13.3 EDITGENE Overexpression Stable Cell Lines Service Introduction
11.13.4 EDITGENE Revenue in Overexpression Stable Cell Lines Service Business (2020-2025)
11.13.5 EDITGENE Recent Development
11.14 System Biosciences, LLC
11.14.1 System Biosciences, LLC Company Details
11.14.2 System Biosciences, LLC Business Overview
11.14.3 System Biosciences, LLC Overexpression Stable Cell Lines Service Introduction
11.14.4 System Biosciences, LLC Revenue in Overexpression Stable Cell Lines Service Business (2020-2025)
11.14.5 System Biosciences, LLC Recent Development
11.15 Acres Biosciences
11.15.1 Acres Biosciences Company Details
11.15.2 Acres Biosciences Business Overview
11.15.3 Acres Biosciences Overexpression Stable Cell Lines Service Introduction
11.15.4 Acres Biosciences Revenue in Overexpression Stable Cell Lines Service Business (2020-2025)
11.15.5 Acres Biosciences Recent Development
11.16 Alstembio
11.16.1 Alstembio Company Details
11.16.2 Alstembio Business Overview
11.16.3 Alstembio Overexpression Stable Cell Lines Service Introduction
11.16.4 Alstembio Revenue in Overexpression Stable Cell Lines Service Business (2020-2025)
11.16.5 Alstembio Recent Development
11.17 Creative Bioarray
11.17.1 Creative Bioarray Company Details
11.17.2 Creative Bioarray Business Overview
11.17.3 Creative Bioarray Overexpression Stable Cell Lines Service Introduction
11.17.4 Creative Bioarray Revenue in Overexpression Stable Cell Lines Service Business (2020-2025)
11.17.5 Creative Bioarray Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
VectorBuilder
System Biosciences
CROBiosystems
Sino Biological
Cyagen
Ubigene
GenScript
AcceGen
Creative Biogene
OriGene
Vitro Biotech
Cusabio
EDITGENE
System Biosciences, LLC
Acres Biosciences
Alstembio
Creative Bioarray
听
听
*If Applicable.
